This International Meeting on “Epigenetics and Epigenomics in Health and Disease” will integrate different sessions on: transcription and chromatin in gene regulation, DNA modifications, RNA epigenetics, non-coding RNA, epigenomic tools. Besides bringing the newest findings on epigenetic mechanisms, a special focus will be dedicated to discuss novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations.
The meeting will gather scientists using diverse approaches, such as molecular biology, cell biology genetics, epigenomics, and biochemistry. Researchers from pharmaceutical companies and clinicians working in different fields but sharing the same interests will also find the meeting an ideal opportunity to meet, discuss and summarize their work.
Furthermore, to ensure that the conference will touch upon the most recent breakthrough in the fast moving field of epigenetics, there will be slots for short talks based on submitted abstracts.
Overall, the meeting will provide great opportunities for senior and junior scientists to meet the leaders in the field from both academia and industry, hence forging exciting interdisciplinary interactions and creating potential new collaborations in the booming area of epigenetics and epigenomics and their clinical impacts.